The FDA is warning of a potential seizure risk associated with e-cigarettes, especially among asolescents and young adults; Sorrento Therapeutics is suing its business partner, alleging he purchased and then tried to prevent the release of their cancer drug; states are suing the Trump administration over plans to loosen school lunch nutrition standards.
The FDA has issued a statement warning of potential seizure risk associated with e-cigarette use. According to the FDA, there have been reports indicating that some people who use e-cigarettes, particularly adolescents and young adults, are experiencing seizures following their use. Since 2010, there have been 35 reported cases, and the reports have lacked enough information to determine a specific brand or sub-brand of e-cigarette. The agency noted that it is not yet clear if there is a direct relationship between the use of e-cigarettes and risk of seizures. Sorrento Therapeutics is suing Patrick Soon-Shiong, MBBCh, MSS, FRCS, alleging that the biotech entrepreneur purchased and then tried to prevent the launch of Sorrento’s experimental cancer drug that would have competed with his blockbuster drug, Abraxane. According to the Los Angeles Times, the legal dispute dates back to 2014 when Sorrento’s drug, Cynviloq, was expected to be approved by the FDA. Soon-Shiong has denied the allegations and said the suits are without merit.Six states and Washington, DC, are suing the Trump administration for plans to roll back the nutrition standards of school lunches implemented by the Obama administration, reported the The Wall Street Journal. The lawsuit is the first to challenge the administration’s plans to loosen the standards, which require carbohydrate-rich foods be made with whole grains with a sodium limit of 640 milligrams. Under the new plan, school lunches would be required to serve whole grains in half of lunch menu items with a sodium limit of 1230 miligrams.